MEDIA CENTER

Overview

Welcome to the Rockland Technimed Ltd. Media Center, where you can review past press releases and news, learn about upcoming events and access publications and abstracts related to our Oxy-17® technology platform.

For media inquiries, please contact: media@OXY-17.com

RTL News

Award
Rockland Technimed Ltd has been awarded the Healthcare & Pharmaceutical Awards 2016 for "Best Theranostic Imaging Company 2016 - USA & Most Disruptive Nano-Technology: OxyFusion™"

v5complogos_TCW_2.jpg
Conference link: http://techconnectworld.com/World2016/
"Rockland Technimed, Ltd. ", has been ACCEPTED to SHOWCASE its disruptive Nano-technology OxyFusion™ MRI medium at this year's TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference, May 23-25, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD.

Rockland Technimed Ltd is a Theranostics company, committed to the early diagnosis and treatment of hypoxic injury. Rockland's disruptive Nano-technology OxyFusion™ MRI medium enriched with its patented Oxy-17® process may set the new Gold standard of Cellular metabolic imaging without radiotracers.
Website: www.oxy-17.com

Hazards of Current Imaging Agent in Use:

Biohazard hazard Reports of Gadolinium:

FDA

Radiological Society of North America

Environmental hazard Reports of Gadolinium:

NIH Report

American Chemical Society

Stanford University


Press Releases

May 2014

Dr Robert DeLaPaz, Medical Director and member of the Board at Rockland Technimed Ltd., presented the following talk on “17O MRI of Cerebral Oxygen Metabolism and Potential Clinical Applications” at the American Society of Neuroradiology 52nd Annual Meeting and the Foundation of the ASNR Symposium 2014.

Rockland Technimed Ltd. Hosted the 8th Annual International Symposium on Metabolic Magnetic Resonance Imaging with Oxy-17®

April 2013

Rockland Technimed Ltd. and Nukem Isotopes GmbH Host 7th Annual International Symposium on Metabolic Magnetic Resonance Imaging with Oxy-17®

May 2012

Rockland Technimed Ltd. Presents Oxy-17® Metabolic Magnetic Resonance Imaging Technology at 2012 Brain Energy Metabolism and Blood Flow Gordon Research Conference

Rockland Technimed Ltd. and Nukem Isotopes GmbH Host 6th Annual International Symposium on Metabolic Magnetic Resonance Imaging with Oxy-17®

Rockland Technimed Ltd. and Nukem Isotopes GmbH Exhibit Oxy-17® Metabolic Magnetic Resonance Imaging Technology at the 20th Annual Meeting of the International Society for Magnetic Resonance in Medicine

May 2011

Rockland Technimed Ltd. and Nukem GmbH Host 5th Annual International Symposium on Metabolic Magnetic Resonance Imaging with Oxy-17®

Rockland Technimed Ltd. and Nukem GmbH Exhibit Oxy-17® Metabolic Magnetic Resonance Imaging Technology at the 19th Annual Meeting of the International Society for Magnetic Resonance in Medicine

 

Global Regulatory News

 

Publications and Abstracts

Click on this link for Publications & Abstracts in PDF format

PDF Brochure

Click the image to view product brochure

 


ABOUT US
Overview
Management Team
Board of Directors
Scientific Advisory Board


TECHNOLOGY
Introducing OxyFusion®
Theranostics
OxyFusion® Uses
Patient Benefits


PRODUCTS
Oxy Fusion
Oxy Gas
Oxy Water


MEDIA CENTER
Overview
News

Press Releases
Publications & Abstracts


CONTACT US